TissueLink Medical

Salient Surgical Technologies, originally founded as TissueLink Medical, is a medical technology company that developed advanced energy-based devices for surgical applications. The company is best known for its proprietary Transcollation technology, which combines radiofrequency energy with saline irrigation to provide hemostatic sealing and coagulation of soft tissue and bone. Its flagship product, the Aquamantys System, is widely utilized in orthopedic, spine, and neurosurgical procedures to significantly reduce blood loss and the need for blood transfusions. Headquartered in Portsmouth, New Hampshire, the company established itself as a leader in the surgical sealing market through its innovative approach to managing intraoperative bleeding. In 2011, Salient Surgical Technologies was acquired by Medtronic for approximately $525 million, integrating its technology into Medtronic's Advanced Energy business. The company's products continue to be a standard of care in various surgical specialties, improving patient outcomes and surgical efficiency.